MXPA05013903A - Metodo para detectar trastornos neoplasicos en una muestra de cuerpo solubilizada. - Google Patents
Metodo para detectar trastornos neoplasicos en una muestra de cuerpo solubilizada.Info
- Publication number
- MXPA05013903A MXPA05013903A MXPA05013903A MXPA05013903A MXPA05013903A MX PA05013903 A MXPA05013903 A MX PA05013903A MX PA05013903 A MXPA05013903 A MX PA05013903A MX PA05013903 A MXPA05013903 A MX PA05013903A MX PA05013903 A MXPA05013903 A MX PA05013903A
- Authority
- MX
- Mexico
- Prior art keywords
- neoplastic disorders
- body sample
- solubilized body
- detecting neoplastic
- tract
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invencion se relaciona con un metodo para el diagnostico temprano de trastornos neoplasicos como canceres asi como sus etapas precursoras, particularmente canceres de tracto respiratorio, el sistema urinario, el tracto reproductivo, cancer asociado con la infeccion HPV o cancer del tracto anogenital, de muestras de cuerpo solubilizadas .El desarrollo de kits y dispositivos de diagnostico in-vitro para el proposito anterior es tambien un aspecto de la presente invencion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03103218A EP1507148B1 (en) | 2003-08-25 | 2003-08-25 | Method for detecting carcinomas in a solubilized cervical body sample |
PCT/EP2004/051872 WO2005088311A1 (en) | 2003-08-25 | 2004-08-20 | Method for detecting neoplastic disorders in a solubilized body sample |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05013903A true MXPA05013903A (es) | 2006-03-09 |
Family
ID=33560881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05013903A MXPA05013903A (es) | 2003-08-25 | 2004-08-20 | Metodo para detectar trastornos neoplasicos en una muestra de cuerpo solubilizada. |
Country Status (14)
Country | Link |
---|---|
US (1) | US7932047B2 (es) |
EP (2) | EP1507148B1 (es) |
JP (2) | JP5619336B2 (es) |
CN (1) | CN1836166B (es) |
AT (2) | ATE289685T1 (es) |
AU (1) | AU2004317284B2 (es) |
BR (1) | BRPI0414030B8 (es) |
CA (1) | CA2528490C (es) |
DE (2) | DE60300339T2 (es) |
ES (1) | ES2342535T3 (es) |
HK (1) | HK1092219A1 (es) |
MX (1) | MXPA05013903A (es) |
RU (1) | RU2405158C2 (es) |
WO (2) | WO2005088311A1 (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7601497B2 (en) | 2000-06-15 | 2009-10-13 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
EP1510820B1 (en) * | 2003-08-25 | 2010-03-17 | MTM Laboratories AG | Method for detecting medically relevant conditions in a solubilized LBC sample |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
US8962262B2 (en) | 2006-05-11 | 2015-02-24 | Arbor Vita Corporation | Method of protein extraction from cells |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
US20100003704A1 (en) * | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
US9207240B2 (en) | 2007-11-14 | 2015-12-08 | Arbor Vita Corporation | Method of efficient extraction of protein from cells |
JP2011511271A (ja) | 2008-01-25 | 2011-04-07 | サイトテック ラブズ リミテッド ライアビリティ カンパニー | 腫瘍原性、腫瘍進行、および処置効率の査定のためのアッセイシステム |
US20090204009A1 (en) * | 2008-02-07 | 2009-08-13 | Los Alamos National Security | Medical device system and related methods for diagnosing abnormal medical conditions based on in-vivo optical properties of tissue |
AU2009289822B2 (en) * | 2008-09-04 | 2015-04-30 | Ventana Medical Systems, Inc. | Method for prediction of the progression risk of tumors |
US8877436B2 (en) | 2008-10-27 | 2014-11-04 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay on an automated platform |
CN101487845B (zh) * | 2009-02-19 | 2013-01-02 | 苏州海路生物技术有限公司 | 大便标本自动检测仪 |
CA2760542A1 (en) | 2009-05-01 | 2010-11-04 | Qiagen Gaithersburg, Inc. | A non-target amplification method for detection of rna splice-forms in a sample |
JP2012526286A (ja) * | 2009-05-07 | 2012-10-25 | オンコヘルス コーポレーション | ヒトパピローマウイルス(hpv)およびhpv関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧cin2の同定 |
CN102822672B (zh) | 2010-01-08 | 2015-12-09 | 安科健康公司 | 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定 |
AU2011210748A1 (en) | 2010-01-29 | 2012-08-09 | Qiagen Gaithersburg, Inc. | Method of determining and confirming the presence of HPV in a sample |
EP2528932B1 (en) | 2010-01-29 | 2016-11-30 | QIAGEN Gaithersburg, Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
US9422593B2 (en) | 2010-05-19 | 2016-08-23 | Qiagen Gaithresburg, Inc | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
US9376727B2 (en) | 2010-05-25 | 2016-06-28 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically truncated probes |
WO2011158847A1 (ja) | 2010-06-17 | 2011-12-22 | 国立大学法人 岡山大学 | microRNA標的遺伝子検出用キット及びmicroRNA標的遺伝子の検出方法 |
GB201014335D0 (en) * | 2010-08-27 | 2010-10-13 | Forensic Science Service Ltd | Improvements in and relating to analysis |
KR20140014064A (ko) | 2010-09-03 | 2014-02-05 | 스템 센트알엑스 인코포레이티드 | 신규한 조절 인자 및 사용 방법 |
CN102033056B (zh) * | 2010-10-14 | 2012-05-30 | 中国科学院化学研究所 | 抑制膜蛋白受体聚集的抗癌药物鉴定方法 |
EP2678442B1 (en) | 2011-02-24 | 2019-01-16 | QIAGEN Gaithersburg, Inc. | Materials and methods for detection of hpv nucleic acid |
CN104067126B (zh) | 2011-11-15 | 2017-04-12 | 迈阿密大学 | 用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法 |
RU2508542C1 (ru) * | 2012-07-16 | 2014-02-27 | Полина Михайловна Шварцбурд | Экспресс-способ определения риска злокачественности клеток |
RU2535071C1 (ru) * | 2013-04-09 | 2014-12-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ диагностики недифференцированной дисплазии соединительной ткани у женщин с потерей беременности в анамнезе |
WO2015017692A1 (en) * | 2013-07-31 | 2015-02-05 | University Of Miami | Compositions and methods for identifying a risk of cancer in a subject |
WO2015147370A1 (en) * | 2014-03-28 | 2015-10-01 | Seegene, Inc. | Detection of target nucleic acid sequences using different detection temperatures |
RU2558987C1 (ru) * | 2014-04-21 | 2015-08-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ диагностики степени тяжести недифференцированной дисплазии соединительной ткани у женщин репродуктивного возраста |
ES2806498T3 (es) | 2015-06-08 | 2021-02-17 | Arquer Diagnostics Ltd | Métodos para el análisis de una muestra de orina |
US11391744B2 (en) | 2015-06-08 | 2022-07-19 | Arquer Diagnostic Limited | Methods and kits |
CN106610434A (zh) * | 2016-02-26 | 2017-05-03 | 弗雷米德生物医药技术(天津)有限公司 | 一种hpv16型e7蛋白的elisa检测试剂盒 |
RU2680930C2 (ru) * | 2017-03-24 | 2019-02-28 | федеральное государственное бюджетное образовательное учреждение высшего образования "Северный государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ забора материала для цитологического исследования при опухолевых заболеваниях поджелудочной железы, печени и желчевыводящих путей |
CN107748265A (zh) * | 2017-09-29 | 2018-03-02 | 中南大学湘雅医院 | Cdc6和ki67在制备癌症放疗抵抗的诊断标记物中的应用 |
MX2020006673A (es) * | 2017-12-29 | 2020-08-31 | Vertex Pharma | Metodos de tratamiento del cancer mediante el uso de un inhibidor de ataxia-telangiectasia mutada y rad3 (atr). |
US11230729B2 (en) | 2018-04-20 | 2022-01-25 | Inanna Diagnostics, Inc | Methods and devices for obtaining cellular and DNA material from human female reproductive system |
CN109781977B (zh) * | 2019-01-09 | 2022-03-29 | 首都医科大学附属北京安定医院 | IL15Rα以及相关膜蛋白检测试剂盒及其应用 |
RU2707099C1 (ru) * | 2019-04-24 | 2019-11-22 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации | Способ скрининга злокачественных опухолей органов грудной полости |
MX2019005940A (es) * | 2019-05-21 | 2019-10-11 | Atso Corp Affairs S A De C V | Biomarcadores relacionados a cancer. |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
EP0584264A1 (en) | 1991-05-16 | 1994-03-02 | Cold Spring Harbor Laboratory | D-type cyclin and uses related thereto |
US5889169A (en) * | 1991-05-16 | 1999-03-30 | Cold Spring Harbor Laboratory | Cell cycle regulatory protein p16 gene |
DE69229960T2 (de) * | 1991-12-13 | 2000-01-05 | Bion Diagnostic Sciences Inc | Agglutierungsassays und kolloide farbstoffe verwendende testsätze |
US6316208B1 (en) * | 1994-01-07 | 2001-11-13 | Memorial Sloan-Kettering Cancer Center | Methods for determining isolated p27 protein levels and uses thereof |
CA2162150C (en) * | 1994-03-18 | 2010-03-30 | Mark H. Skolnick | Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
US6060301A (en) * | 1994-03-18 | 2000-05-09 | Myriad Genetics, Inc. | Vector containing MTS1E1β gene |
US5989815A (en) * | 1994-03-18 | 1999-11-23 | University Of Utah Research Foundation | Methods for detecting predisposition to cancer at the MTS gene |
CA2164167A1 (en) | 1994-12-20 | 1996-06-21 | Izak Bahar | Assay normalization method |
US6033847A (en) * | 1995-02-06 | 2000-03-07 | St. Jude Children's Research Hospital | InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
US5843756A (en) * | 1995-06-07 | 1998-12-01 | Myriad Genetics, Inc. | Mouse MTSI gene |
US6403383B1 (en) * | 1996-03-11 | 2002-06-11 | American Bio Medica Corp. | Diagnostic test kit for immunological assays of fluid samples |
US5976799A (en) * | 1996-03-21 | 1999-11-02 | The Board Of Trustees Of The University Of Arkansas | Early detection of ovarian carcinoma using P16 gene products |
US5858683A (en) * | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
WO1999004238A2 (en) | 1997-07-15 | 1999-01-28 | Mitotix, Inc. | Reagents and methods for diagnosis and prognosis of proliferative disorders |
US6090579A (en) * | 1997-08-12 | 2000-07-18 | Smithkline Beecham Corporation | Human SDR2 cDNA clone |
PT1038022E (pt) | 1997-12-12 | 2005-11-30 | Digene Corp | Avaliacao de doencas relacionadas com o virus papiloma humano |
US20010051364A1 (en) * | 1997-12-23 | 2001-12-13 | Francis Michon | Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines |
US6686151B1 (en) | 1998-02-06 | 2004-02-03 | Digene Corporation | Immunological detection of RNA:DNA hybrids on microarrays |
US7399589B2 (en) * | 1998-02-06 | 2008-07-15 | Digene Corporation | Immunological detection of RNA:DNA hybrids on microarrays |
US5994079A (en) * | 1998-02-06 | 1999-11-30 | Digene Corporation | Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function |
US6576420B1 (en) * | 1998-06-23 | 2003-06-10 | Regents Of The University Of California | Method for early diagnosis of, and determination of prognosis in, cancer |
US7306926B2 (en) * | 1998-07-01 | 2007-12-11 | Mtm Laboratories Ag | Method for detecting carcinomas in a solubilized cervical body sample |
DE19829473C2 (de) * | 1998-07-01 | 2000-08-10 | Magnus Von Knebel Doeberitz Ch | Verfahren zur frühen Diagnose von Carcinomen |
US6593084B2 (en) * | 1998-10-13 | 2003-07-15 | Robert E. Bird | Carcinogen assay |
WO2000031538A1 (en) * | 1998-11-23 | 2000-06-02 | Praxsys Biosystems, Inc. | Improved lateral flow assays |
SE515668C2 (sv) * | 1999-02-22 | 2001-09-17 | Quantovir Ab | Metod och kit för tidig förutsägelse av cancer |
DE10014685B4 (de) * | 2000-03-24 | 2004-07-01 | Schubert, Walter, Dr. | Verfahren zur Identifizierung von zellspezifischen Zielstrukturen |
GB0018140D0 (en) | 2000-07-24 | 2000-09-13 | Medical Res Council | Screening for abnormalities |
DE10063179A1 (de) | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern |
ITRM20010363A1 (it) * | 2001-06-25 | 2001-09-24 | Franco Castelmani | Gancio adattivo applicato ad un generatore di vivrazioni sinusoidali. |
ES2282599T3 (es) * | 2002-01-07 | 2007-10-16 | Norchip A/S | Metodo para detectar arnm del virus del papiloma humano. |
EP1333278B1 (en) | 2002-02-01 | 2004-03-10 | MTM molecular tools in medicine | Methods for monitoring and prognosis of disease course of gastrointestinal tumors |
DK1388734T3 (da) | 2002-08-01 | 2004-05-03 | Mtm Lab Ag | Metode til opløsningsbaseret diagnose |
US7361460B2 (en) | 2003-04-11 | 2008-04-22 | Digene Corporation | Approach to molecular diagnosis of human papillomavirus-related diseases |
-
2003
- 2003-08-25 AT AT03103218T patent/ATE289685T1/de not_active IP Right Cessation
- 2003-08-25 DE DE60300339T patent/DE60300339T2/de not_active Expired - Lifetime
- 2003-08-25 EP EP03103218A patent/EP1507148B1/en not_active Expired - Lifetime
-
2004
- 2004-08-20 CA CA2528490A patent/CA2528490C/en active Active
- 2004-08-20 CN CN2004800230648A patent/CN1836166B/zh active Active
- 2004-08-20 US US10/569,758 patent/US7932047B2/en active Active
- 2004-08-20 RU RU2006101395/15A patent/RU2405158C2/ru active
- 2004-08-20 BR BRPI0414030A patent/BRPI0414030B8/pt active IP Right Grant
- 2004-08-20 DE DE602004026014T patent/DE602004026014D1/de active Active
- 2004-08-20 MX MXPA05013903A patent/MXPA05013903A/es active IP Right Grant
- 2004-08-20 EP EP04821633A patent/EP1664788A1/en not_active Ceased
- 2004-08-20 AU AU2004317284A patent/AU2004317284B2/en not_active Expired
- 2004-08-20 AT AT04104026T patent/ATE461449T1/de not_active IP Right Cessation
- 2004-08-20 WO PCT/EP2004/051872 patent/WO2005088311A1/en active Application Filing
- 2004-08-20 JP JP2006524363A patent/JP5619336B2/ja active Active
- 2004-08-20 ES ES04104026T patent/ES2342535T3/es active Active
- 2004-08-25 WO PCT/EP2004/051903 patent/WO2005084103A2/en unknown
-
2006
- 2006-12-20 HK HK06113997.0A patent/HK1092219A1/xx unknown
-
2011
- 2011-11-14 JP JP2011249079A patent/JP5677270B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
DE60300339D1 (de) | 2005-03-31 |
US7932047B2 (en) | 2011-04-26 |
CA2528490C (en) | 2015-11-03 |
BRPI0414030B8 (pt) | 2021-07-27 |
JP2007503208A (ja) | 2007-02-22 |
EP1664788A1 (en) | 2006-06-07 |
ES2342535T3 (es) | 2010-07-08 |
AU2004317284B2 (en) | 2009-11-05 |
BRPI0414030A (pt) | 2007-01-23 |
ATE289685T1 (de) | 2005-03-15 |
CN1836166A (zh) | 2006-09-20 |
JP2012032412A (ja) | 2012-02-16 |
WO2005088311A1 (en) | 2005-09-22 |
EP1507148A1 (en) | 2005-02-16 |
JP5619336B2 (ja) | 2014-11-05 |
AU2004317284A1 (en) | 2005-09-22 |
WO2005084103A2 (en) | 2005-09-15 |
ATE461449T1 (de) | 2010-04-15 |
JP5677270B2 (ja) | 2015-02-25 |
EP1507148B1 (en) | 2005-02-23 |
US20070190529A1 (en) | 2007-08-16 |
BRPI0414030B1 (pt) | 2017-04-04 |
DE60300339T2 (de) | 2006-04-13 |
DE602004026014D1 (de) | 2010-04-29 |
CA2528490A1 (en) | 2005-09-22 |
RU2405158C2 (ru) | 2010-11-27 |
CN1836166B (zh) | 2010-05-26 |
RU2006101395A (ru) | 2006-06-10 |
HK1092219A1 (en) | 2007-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05013903A (es) | Metodo para detectar trastornos neoplasicos en una muestra de cuerpo solubilizada. | |
EP1842065A4 (en) | METHODS OF DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS | |
WO2004067570A3 (en) | Prostate cancer diagnosis and treatment | |
EP2301626A3 (en) | Antibiotic for use in local infection | |
AU2003213594A1 (en) | Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples | |
ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
MX2009003562A (es) | Ensayo elisa para la deteccion de vegf. | |
WO2002035232A3 (en) | Method for detecting ovarian cancer based on human kallikrein 6 (hk6) | |
WO2002061148A3 (en) | Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma | |
WO2002088706A3 (en) | Process for differential diagnosis of alzheimer's dementia and device therefor | |
WO2009024691A3 (fr) | Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal | |
WO2005113831A3 (en) | Biomarkers for multiple sclerosis and methods of use thereof | |
WO2002086448A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
WO2007146668A3 (en) | Use of imp3 as a prognostic marker for cancer | |
WO2009019369A3 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal | |
IL164098A0 (en) | Methods and compositions for analysis of urine samples in the diagnosis of kidney diseases | |
AU2002306568A1 (en) | Forms of prostate specific antigens and methods for their detection | |
WO2002023200A3 (en) | Human breast cancer biomarkers | |
WO2004063710A8 (en) | Mark-pap system (method, kit, solution & accessories) processes for producing and using the same | |
SE0002287D0 (sv) | Biotinderivat | |
Wiwanitkit | Urinary bladder carcinoma and human papilloma virus infection, an appraisal of risk | |
WO2005017183A3 (en) | Methylated gene biomarkers for detecting cancer | |
AU7476101A (en) | Biotin derivatives | |
AP2004003118A0 (en) | A vehicle for the medical treatment of persons in remote areas | |
MY147511A (en) | Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3-marker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
HC | Change of company name or juridical status |